ArticleBMC public health2026
Sociodemographic predictors of glycaemic control among adults with type 2 diabetes mellitus in a Nigerian population: implications for public health and service delivery.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) represents a rising public health burden in Nigeria. Although its clinical impact is well documented, evidence on how sociodemographic characteristics relate to glycaemic outcomes in various Nigerian populations remain limited. This study therefore sought to identify the independent sociodemographic factors associated with poor glycaemic control among Nigerian adults with T2DM.
methodsA retrospective, multi-centre, cross-sectional study was conducted using records from five specialist clinics in Enugu State, Nigeria, comprising N = 1,030 adults with T2DM. Glycaemic control was defined using the last recorded HbA1c value, with poor control classified as ≥ 7.0%. Predictors were analysed using binary logistic regression and stratified analyses were performed by sex, disease duration, and comorbid hypertension status to test for effect modification. A p-value < 0.05 was considered statistically significant for all analyses.
resultThe prevalence of poor glycaemic control was 32.2%. Independent factors associated with poor glycaemic control in the overall model were female sex (AOR = 1.75), older age (AOR = 2.15), and longer diabetes duration (AOR = 5.77). Stratified analyses demonstrated that the association with long disease duration was markedly stronger for women than for men, while comorbid hypertension was a significant factor only among males. Also, poor glycaemic control in the early phase was significantly associated with comorbid hypertension (AOR = 2.59) and older age (AOR = 2.26), whereas in the late phase it was associated with female sex (AOR = 2.89) and a borderline association with low socioeconomic status (p = 0.051). No significant interaction was observed between age and diabetes duration.
conclusionThe factors related to poor glycaemic control differ according to disease duration, involving clinical factors in the early stage and social challenges in long-standing disease. These findings highlight the need to move toward targeted interventions, such as intensive early comorbidity management for men and sustained social support for women, to address the unique vulnerabilities of patients in Nigeria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.